Patrick G. Lepore is Chairman at PAR PHARMACEUTICAL COMPANIES, INC. (PRX). They have made 27 open-market trades across 4 companies since 2007, most recently 2025-01-15.
CIK 0001055404
26 open-market purchases totalling $3.1M since 2007, against 1 sale. Across 23 scored buys the stock is down 8.4% at ninety days, and 12.2 points behind the S&P over the same stretch.
23 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 52% | 35% | 30% |
| Avg Move | +1.4% | +0.7% | -8.4% |
| Alpha | +1.1% | -0.4% | -12.2% |
| Scored | 23 | 23 | 23 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYNE | BUY | 2025-01-15 | 2025-01-16 | $2.92 | $44K | -11.3% | -11.3% | -36.0% |
| VYNE | BUY | 2023-11-15 | 2023-11-17 | $3.91 | $51K | -17.3% | -36.5% | -46.0% |
| VYNE | BUY | 2023-03-20 | 2023-03-22 | $2.48 | $50K | +13.8% | +59.6% | +92.7% |
| LCI | BUY | 2022-11-10 | 2022-11-14 | $0.49 | $49K | +42.6% | +20.8% | +34.7% |
| LCI | BUY | 2022-05-16 | 2022-05-17 | $0.54 | $27K | -11.9% | +6.3% | +2.3% |
| LCI | BUY | 2022-02-08 | 2022-02-10 | $0.88 | $44K | -10.2% | -12.1% | -43.5% |
| VYNE | BUY | 2021-11-30 | 2021-12-02 | $1.02 | $13K | +25.8% | +21.5% | -40.4% |
| LCI | BUY | 2021-11-29 | 2021-11-30 | $1.71 | $86K | +18.8% | +0.0% | -49.7% |
| LCI | BUY | 2021-09-08 | 2021-09-09 | $3.31 | $66K | -10.1% | -20.6% | -39.1% |
| VYNE | BUY | 2021-08-25 | 2021-08-26 | $1.60 | $20K | +2.6% | -1.9% | -31.6% |
| VYNE | BUY | 2021-05-26 | 2021-05-27 | $3.60 | $45K | +9.3% | -2.9% | -57.9% |
| LCI | BUY | 2021-05-11 | 2021-05-12 | $4.18 | $84K | +5.0% | +18.1% | +2.9% |
| VYNE | BUY | 2021-03-15 | 2021-03-16 | $7.41 | $93K | -8.5% | -27.1% | -49.1% |
| VYNE | BUY | 2020-12-03 | 2020-12-07 | $1.71 | $86K | -1.7% | -7.3% | -10.5% |
| MTNB | BUY | 2020-05-14 | 2020-05-18 | $0.73 | $73K | +4.0% | -5.8% | -0.8% |
| MTNB | BUY | 2019-11-15 | 2019-11-19 | $1.06 | $106K | -1.5% | +38.5% | +0.0% |
| LCI | BUY | 2019-09-03 | 2019-09-05 | $9.82 | $246K | +19.2% | +6.4% | -25.1% |
| MTNB | BUY | 2019-08-16 | 2019-08-20 | $0.72 | $72K | +3.0% | -12.4% | +84.4% |
| MTNB | BUY | 2019-05-16 | 2019-05-20 | $0.95 | $95K | -5.9% | -19.0% | -32.8% |
| LCI | BUY | 2019-05-08 | 2019-05-09 | $7.32 | $183K | -12.1% | -18.5% | -4.6% |
| LCI | BUY | 2019-02-12 | 2019-02-13 | $8.93 | $223K | +2.1% | -9.8% | -38.2% |
| LCI | BUY | 2018-12-13 | 2018-12-17 | $5.10 | $255K | +9.0% | +60.9% | +68.4% |
| LCI | BUY | 2018-08-31 | 2018-09-04 | $5.34 | $134K | -9.6% | -13.7% | +0.9% |
| LCI | BUY | 2018-05-11 | 2018-05-14 | $15.13 | $378K | +3.8% | +4.8% | -14.0% |
| PRX | BUY | 2011-09-06 | 2011-09-07 | $25.92 | $207K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.